Company / Return on Assets (ROA)
Dyne Therapeutics, Inc. Return on Assets (ROA) History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-45.9%
FY2024
5-year range
-142.9% / -16.8%
FY2020-FY2024
Trend
+67.9%
vs FY2023
Sector context
#173 of 213
Health Care
What the data says
Dyne Therapeutics, Inc.'s return on assets (roa) of -45.9% is lower than 81% of companies in the Health Care sector (FY2024). Return on Assets (ROA) returned to growth in FY2024 after 3 years of decline, reaching -45.9%.
Based on SEC 10-K filings.
-45.9% in FY2024 with a 5-year CAGR of +44.5%.
Improved from -54.9% to -45.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -10.8pp
- 5-Year Change
- +44.5pp
- 10-Year Change
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 213This company -45.9% Sector average -24.1%
▼
-90.9% below sector average
Key checks
Key Insights
- In FY2024, return on assets (roa) increased 67.9% year-over-year.
- Currently 21.9pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -45.9% | +67.9% |
| FY2023 | -142.9% | -160.4% |
| FY2022 | -54.9% | -56.5% |
| FY2021 | -35.1% | -108.5% |
| FY2020 | -16.8% | +81.4% |
| FY2019 | -90.4% | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026